Opportunity timeline
In plain English
The VA plans to award Natera a sole-source contract for molecular laboratory tests used to monitor transplant patients and cancer residual disease. Estimated quantities are 35 Signatera tests and 25 Prospera tests for VA facilities in Texas, across five ordering periods. This is not a request for quotes; companies claiming they can provide an equivalent test may email a capability statement by November 2, 2026, at 10:00 a.m. CST.
About this opportunity
Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3
1. NOTICE OF INTENT DESCRIPTION
The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease.
2. SUPPLIES/SERVICES
Time remaining
Closes Oct 30, 2026
Related Opportunities

FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334)

Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

NCEPC 2027 SCI - Science Supplies

Laboratory Support Services

NWI Offsite Pathology Services
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-CC20E0

